Product ID |
Product Name |
CAS# |
Purity |
Y1237028 |
4-[[[3-(3,4-Dimethoxyphenyl)imidazo[1,2-b]pyridazin-6-yl]amino]methyl]benzenesulfonamide |
1012343-93-9 |
98% |
Y3177249 |
1-(4-Hydroxycyclohexyl)-2-[[5-(2-trifluoromethoxyphenyl)-1H-indazol-3-yl]amino]-1H-benzimidazole-5-carboxylic acid (3-methylbutyl)amide |
1012104-68-5 |
95% |
D761890 |
Methyl 2-(2-(5-chloro-2-phenoxyphenyl)-N-MethylacetaMido)acetate |
1180843-76-8 |
98% |
D761618 |
Methyl 2-Methoxy-4-Methyl-5-nitrobenzoate |
1057652-79-5 |
96% |
D761671 |
Methyl 3-(2,6-difluorophenylcarbaMoyl)-4-Methoxybenzoate |
1089278-51-2 |
97% |
D761434 |
Methyl 3'-(ethylsulfonyl)-4-Methyl-5-nitrobiphenyl-3-carboxylate |
1005499-49-9 |
98% |
Y1237168 |
MK 5172 potassiuM salt |
1206524-86-8 |
99% |
Y1237123 |
1-(4-(4-(2-(isopropylsulfonyl)phenylamino)-1H-pyrrolo[2,3-b]pyridin-6-ylamino)-3-methoxyphenyl)piperidin-4-ol |
1125593-20-5 |
99% |
Y1237169 |
MTOR inhibitor |
1207358-59-5 |
99% |
Y1237153 |
PDK1 inhibitor |
1001409-50-2 |
99% |
Y1047758 |
Peramivir |
1041434-82-5 |
98+% |
Y1236456 |
PF-04620110 |
1109276-89-2 |
99% |
D761427 |
Phenol, p-(1-benzyl-2-benziMidazolyl)- |
10206-01-6 |
98% |
Y1013815 |
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate |
1019206-88-2 |
98+% |
Y3311277 |
Ethanone, 1-[6,7-dihydro-4-[(3-Methylphenoxy)Methyl]thieno[3,2-c]pyridin-5(4H)-yl]-2-[(2-Methylbutyl)aMino]- |
1043797-53-0 |
99% |
Y1267074 |
SMND-309 |
1065559-56-9 |
96% |
D761447 |
sodiuM 4-pentynoate |
101917-30-0 |
95% |
D964608 |
5-((6-(2,4-bis(TrifluoroMethyl)phenyl)pyridazin-3-yl)Methyl)-2-(2-fluorophenyl)-5H-iMidazo[4,5-c]pyridine |
1000787-75-6 |
98+% |
Y1342878 |
(2S)-2-aMino-3-[4-[2-aMino-6-[(1R)-1-[4-chloro-2-(3-Methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyriMidin-4-yl]phenyl]propanoic acid, Telotristat |
1033805-28-5 |
97% |
Y1232755 |
Tenovin 6 (Hydrochloride) |
1011301-29-3 |
98% |
Y1232804 |
VD3-D6 |
118584-54-6 |
99% |
Y1313748 |
CARBAMIC ACID, N-[2-[(R)-(3-CHLOROPHENYL)[(3R)-1-[[[(2S)-2-(METHYLAMINO)-3-[(3R)-TETRAHYDRO-2H-PYRAN-3-YL]PROPYL]AMINO]CARBONYL]-3-PIPERIDINYL]METHOXY]ETHYL]-, METHYL ESTER, 2,2,2-TRIFLUOROACETATE (1 |
1013937-63-7 |
98% |
Y3297434 |
Zileuton (sodiuM) |
118569-21-4 |
98% |
Y1232823 |
(±)-Methotrimeprazine (D6) |
1189805-51-3 |
98% |
D770270 |
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-(2-aminoethyl)-6-(dimethylamino)- |
1051373-06-8 |
98% |
Y3216393 |
Nintedanib |
1174335-83-1 |
95% |
D770271 |
2-Furancarboxylic acid, 5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)- |
1047629-15-1 |
96% |
D761813 |
7-Bromo-2,3-dihydropyrano[4,3,2-de]quinoline |
1155270-72-6 |
98% |
D770274 |
7-Bromo-5-chloro-2,3-dihydropyrano[4,3,2-de]quinoline |
1155270-71-5 |
95+% |
D770275 |
Acetamidomalonic acid (disodium salt) |
117976-12-2 |
95+% |
Y3170350 |
ACETAZOLAMIDE-D3 |
1189904-01-5 |
99% |
Y1232805 |
4-(2-HYDROXYETHYLAMINO)-2-(4-METHOXYPHENYLAMINO)-PYRIMIDINE HYDROCHLORIDE |
1049741-55-0 |
98% |
Y1232800 |
CARM1-IN-1 |
1020399-49-8 |
95% |
Y1232801 |
Dextrorotation nimorazole phosphate ester |
1124347-33-6 |
98% |
D770276 |
Estrane, 1,6-hexanediamine deriv. |
112646-70-5 |
98% |
Y1237067 |
Gadoteridol |
120066-54-8 |
98% |
Y1237047 |
GSK2190915 (sodiuM salt) |
1196070-26-4 |
99% |
Y1232764 |
(-)-BETA-HYDRASTINE |
118-08-1 |
99% |
D761959 |
ICARITIN |
118525-40-9 |
98+% |
Y3310090 |
dl-Benflumelol-d18 |
1185240-53-2 |
100% |
Y3237305 |
MAChR-IN-1 |
119391-56-9 |
95% |
D770277 |
Methyl (4S)-4-(tritylamino)cyclopent-1-ene-1-carboxylate |
1113025-21-0 |
97% |
Y3172631 |
Midodrine-d6, Hydrochloride |
1188265-43-1 |
98% |
Y3177250 |
N-Desmethyl Clomipramine-d3 Hydrochloride |
1189971-04-7 |
99% |
Y1237063 |
NMS-P715 |
1202055-32-0 |
98% |
Y1232812 |
p38 MAPK-IN-1 |
1006378-90-0 |
98% |
Y1232813 |
PDE4 (R)-(-)-RolipraM |
1160521-50-5 |
98% |
Y3288249 |
D-Tryptophan (2E)-2-(6-quinoxalinylmethylene)hydrazide |
1173671-63-0 |
98% |
Y3295935 |
TRIAMTERENE-D5 |
1189922-23-3 |
99% |
Y1262835 |
TubeiMoside II |
115810-12-3 |
99% |
Y3293240 |
TZ-9 |
1002789-86-7 |
99% |
Y1258309 |
L-Valine, N-(1-oxopentyl-d9)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]Methyl]- |
1089736-73-1 |
98% |
Y1258331 |
GSK2256294A |
1142090-23-0 |
99% |
D761464 |
1,3,5-TRIS(4-AMINOPHENOXY)BENZENE (135TAPOB) |
102852-92-6 |
98% |
D491111 |
5-broMo-6-fluoroindoline-2,3-dione |
118897-99-7 |
95% |
Y3169246 |
AcetaMide, N-[3-(aMinooxy)propyl]-, hydrochloride |
1134749-42-0 |
95% |
Y1262837 |
AN3199 |
1187187-10-5 |
99% |
D963630 |
CarbaMic acid, N-[3-[5-(2,5-difluorophenyl)-2,3-dihydro-3-[(MethoxyMethylaMino)carbonyl]-2-phenyl-1,3,4-thiadiazol-2-yl]propyl]-, 1,1-diMethylethyl ester |
1079843-60-9 |
98% |
D761893 |
5-amino-2,4-di-tert-butylphenyl methyl carbonate |
1182822-31-6 |
95+% |
Y1237064 |
D3263 HCl salt |
1008763-54-9 |
98% |
D761525 |
D-Glucopyranoside, Methyl 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]- |
1030825-21-8 |
98+% |
D964755 |
diethyl 9-ethoxynonylphosphonate |
1052137-31-1 |
98% |
D761907 |
D-Norvaline, N-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester |
116611-58-6 |
98+% |
Y1336235 |
2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3 |
104121-92-8 |
99% |
D761925 |
EMD638683 |
1181770-72-8 |
98+% |
Y1232837 |
(alphaR)-3,5-Difluoro-alpha-hydroxybenzeneacetic acid 2-(2-ethyl-4-hydroxy-3-methylbenzoyl)hydrazide |
1184940-47-3 |
99% |
Y1237025 |
(alphaS)-3,5-difluoro-alpha-hydroxybenzeneacetic acid 2-(2-ethyl-4-hydroxy-3-methylbenzoyl)hydrazide |
1184940-46-2 |
99% |
D770265 |
Fesoterodine ((S)-2-hydroxy-2-phenylacetic acid) |
1206695-46-6 |
98% |
Y1237180 |
FGH-10019 |
1046045-61-7 |
99% |
D761639 |
Furo[2,3-d]pyriMidin-4(3H)-one, 5,6-diphenyl- |
106561-29-9 |
98% |
Y1237026 |
Benzenepropanoic acid, 4-[[4-(2-chlorophenyl)-2-thiazolyl]methoxy]-2-methyl- |
1050506-87-0 |
98% |
D770266 |
HeptanaMide, 3-aMino-N-cyclopropyl-2-hydroxy-, (Hydrochloride) (1 |
1137141-25-3 |
97% |
Y1290113 |
3-PYRIDINECARBOXAMIDE, 6-(3-FLUOROPHENYL)-N-[1-(2,2,2-TRIFLUOROETHYL)-4-PIPERIDINYL]- |
1033836-12-2 |
98% |
Y1241726 |
Thieno[3,2-d]pyriMidin-4-aMine, N-[(1S)-2-[4-[(3,4-dichlorophenyl)sulfonyl]-1-piperazinyl]-1-Methylethyl]-7-Methyl- |
1017606-66-4 |
99% |
D962708 |
L-ValinaMide, N,N-diMethyl-L-valyl-N-[(1S,2R)-4-(1,1-diMethylethoxy)-2-Methoxy-1-[(1S)-1-Methylpropyl]-4-oxobutyl]-N-Methyl- |
120205-53-0 |
95% |
Y1237189 |
LY 2801653 dihydrochloride |
1206801-37-7 |
99% |
Y1241593 |
MAC-13243 |
1071638-38-4 |
98% |
D758374 |
AB 1010 Mesylate |
1048007-93-7 |
98+% |
Y1237181 |
Methyl 5-(4-Bromophenylamino)-4-Fluoro-1-Methyl-1H-Benzo[D]Imidazole-6-Carboxylate |
1000340-06-6 |
95% |
Y1237152 |
4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid |
1006036-87-8 |
98% |
Y1246086 |
4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid sodium salt |
1006036-88-9 |
98% |
Y1237190 |
MK-4827 (HCl) |
1038915-64-8 |
99% |
D761465 |
N7,N7-diMethyl-3-M-tolylisoquinoline-1,7-diaMine 277.3636 |
1029008-73-8 |
98% |
Y3179946 |
OLPRINONE HYDROCHLORIDE |
119615-63-3 |
98%(HPLC) |
D964877 |
(S)-2-(3,4-Difluorophenyl)oxirane |
1006376-63-1 |
95% |
Y1237182 |
PDE-9 |
1082743-70-1 |
99% |
D761976 |
Propanoic acid, 2-(acetyloxy)-, 1,1-diMethylethyl ester, (2S)- |
120444-05-5 |
98+% |
Y1267127 |
PSI-7976 |
1190308-01-0 |
98% |
D962901 |
Pyrido[3,4-d]pyriMidine-7(6H)-carboxylic acid, 2-[4-[[(ethylaMino)carbonyl]aMino]phenyl]-5,8-dihydro-4-[(3S)-3-Methyl-4-Morpholinyl]-, 1,1-diMethylethyl ester |
1207365-47-6 |
98% |
Y1267073 |
rac-Rotigotine Hydrochloride |
102120-99-0 |
98% |
Y1267128 |
SodiuM Channel inhibitor 1 |
1198117-23-5 |
98% |
Y1342983 |
LMV-601 |
1096687-52-3 |
98% |
Y1267166 |
N-[2-[[(2,3-Difluorophenyl)methyl]thio]-6-[[(1S,2R)-2,3-dihydroxy-1-methylpropyl]amino]-4-pyrimidinyl]-1-azetidinesulfonamide |
1204707-73-2 |
99% |
Y1262840 |
TAK-593 |
1005780-62-0 |
99% |
Y1339588 |
tert-butyl 2-benzyl-1-oxo-2,5-diazaspiro[3.4]octane-5-carboxylate |
1206970-01-5 |
97% |
D963039 |
tert-butyl 2'-oxo-1'-((2-(triMethylsilyl)ethoxy)Methyl)-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridine]-5-ylcarbaMate |
1033608-31-9 |
97% |
D964556 |
tert-butyl 8-(3,5-difluorophenyl)-9-(2-ethoxy-2-oxoethyl)-10-oxo-6,9-diazaspiro[4.5]decane-6-carboxylate |
1206821-43-3 |
98% |
D770267 |
Tricyclo[2.2.1.02,6]heptanone, 5-[(acetyloxy)Methyl]- (9CI) |
110770-75-7 |
97% |
D770268 |
(5-(4-chlorophenyl)thiophen-2-yl)boronic acid |
1210470-48-6 |
98% |
Y1232792 |
(S)-Gossypol (acetic acid) |
1189561-66-7 |
99% |